Glucox Biotech AB
Records under this name other than the patents Glucox Biotech AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 1 of 1 · Back to Glucox Biotech AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,687,490 | Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase Lapsed on the fee record Ended Jun 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 27, 2021 | From the USPTO record |